Selective loss of innate CD4+ Vα24 natural killer T cells in human immunodeficiency virus infection

Journal of Virology

Volumn 76, Issue 15, 2002, Pages 7528-7534

  Sandberg, Johan K ^a   Fast, Noam M ^a   Palacios, Emil H ^a   Fennelly, Glenn ^a   Dobroszycki, Joanna ^a   Palumbo, Paul ^a   Wiznia, Andrew ^a   Grant, Robert M ^a   Bhardwaj, Nina ^a   Rosenberg, Michael G ^a   Nixon, Douglas F ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; HOMING RECEPTOR; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; PADGEM PROTEIN;

ADULT; ARTICLE; CHILD; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOPHENOTYPING; IMMUNOREGULATION; LYMPHOCYTE COUNT; LYMPHOCYTE DEPLETION; LYMPHOCYTE HOMING; MAJOR CLINICAL STUDY; NATURAL KILLER CELL; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; VIREMIA; VIRUS LOAD;

ADULT; ANTIGENS, SURFACE; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CHILD; HIV INFECTIONS; HIV-1; HUMANS; KILLER CELLS, NATURAL; L-SELECTIN; LECTINS, C-TYPE; LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; RECEPTORS, LYMPHOCYTE HOMING; T-LYMPHOCYTE SUBSETS;

EID: 0036310371     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.76.15.7528-7534.2002     Document Type: Article

References (45)

1. HIV-1 gp120-specific antibody-dependent cell-mediated cytotoxicity correlates with rate of disease progression
2. A new classification for HIV-1
3. Natural killer cells in antiviral defense: Function and regulation by innate cytokines
4. Cutting edge: Cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells
5. Change in coreceptor use coreceptor use correlates with disease progression in HIV-1-infected individuals
6. Cardiac autoimmunity in HIV related heart muscle disease
7. Close phenotypic and functional similarities between human and murine αbeta T cells expressing invariant TCR alphachains
8. - T cells
9. + natural T cells with distinct cytotoxic activities and Th1, Th2, and ThO cytokine secretion patterns
10. Induction of IFN-gamma-producing CD4+ natural killer T cells by Mycobacterium bovis bacillus Calmette Guerin
11. - T cells
12. + patients produce C-C chemokines and inhibit HIV-1 infection
13. NKT cells: Facts, functions and fallacies
14. The epidemiology of acquired immunodeficiency syndrome malignancies
15. Isolation of mycobacterium-reactive CD1-restricted T cells from patients with human immunodeficiency virus infection
16. - (NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin (IL)-4 and/or IL-10
17. The natural killer T-cell ligand alpha-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice
18. Differential expression of NK T cell V alpha 24J alpha Q invariant TCR chain in the lesions of multiple sclerosis and chronic inflammatory demyelinating polyneuropathy
19. Distinct cytokine profiles of neonatal natural killer T cells after expansion with subsets of dendritic cells
20. Natural killer T cell activation inhibits hepatitis B virus replication in vivo
21. The natural killer T (NKT) cell ligand alpha-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells
22. Overexpression of natural killer T cells protects Vα14-Jα281 transgenic nonobese diabetic mice against diabetes
23. The importance of the innate immune system in controlling HIV infection and disease
24. Controlling HIV pathogenesis: The role of the noncytotoxic anti-HIV response of CD8+ T cells
25. Treatment of hepatic metastasis of the colon26 adenocarcinoma with an alpha-galactosylceramide, KRN7000
26. Cutting edge: Cytolytic effector function in human circulating CD8+ T cells closely correlates with CD56 surface expression
27. Phosphoantigen-reactive Vγ9Vδ2 T lymphocytes suppress in vitro human immunodeficiency virus type 1 replication by cell-released antiviral factors including CC chemokines
28. - alpha/beta T cells demonstrates preferential use of several V beta genes and an invariant TCR alpha chain
29. The CD1 system: Antigen-presenting molecules for T cell recognition of lipids and glycolipids
30. The AIDS disease of CD4c/HIV transgenic mice shows impaired germinal centers and autoantibodies and develops in the absence of IFN-gamma and IL-6
31. Sensing pathogens and tuning immune responses
32. Different dysregulations of the natural antibody repertoire in treated and untreated HIV-1 patients
33. Reciprocal control of T helper cell and dendritic cell differentiation
34. Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune type 1 diabetes
35. The nature of the principal type 1 interferon-producing cells in human blood
36. Differential tumor surveillance by natural killer (NK) and NKT cells
37. CD1-reactive natural killer T cells are required for development of systemic tolerance through an immune-privileged site
38. Depletion of circulating natural type 1 interferon-producing cells in HIV-infected AIDS patients
39. T lymphocyte recognition of human group 1 CD1 molecules: Implications for innate and acquired immunity
40. Selective reduction of T cells bearing invariant V alpha 24J alpha Q antigen receptor in patients with systemic sclerosis
41. Analysis of human V alpha 24+ CD4+ NKT cells activated by alpha-glycosylceramide-pulsed monocyte-derived dendritic cells
42. Human immunodeficiency virus envelope V1 and V2 regions influence replication efficiency in macrophages by affecting virus spread
43. Human natural killer T cells acquire a memory-activated phenotype before birth
44. Extreme Th1 bias of invariant Vα24JαQ T cells in type 1 diabetes
45. CD1d on myeloid dendritic cells stimulates cytokine secretion from and cytolytic activity of V alpha 24J alpha Q T cells: A feedback mechanism for immune regulation